申请人:Flohr Alexander
公开号:US20120142665A1
公开(公告)日:2012-06-07
The invention is concerned with triazolopyridine compounds of formula (I)
wherein R
1
, R
2
, R
3
and R
4
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as pharmaceuticals.
本发明涉及通式(I)的三唑并吡啶化合物,其中R1、R2、R3和R4如说明书和权利要求中所定义,以及其生理上可接受的盐。这些化合物抑制PDE10A,可用作药物。